MGAT4D is a Golgi-localized protein that functions as a specific inhibitor of MGAT1 (mannosyl (alpha-1,3-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase), the enzyme initiating complex and hybrid N-glycan synthesis 1. The inhibitory mechanism is mediated by MGAT4D's luminal domain, which directly interacts with MGAT1 in the Golgi without generating catalytic activity 1. This interaction causes cell surface proteins to accumulate high mannose N-glycans instead of complex glycans 2. The C-terminal PSLFQ sequence is critical for MGAT1 inhibition, with Leu-395 and Phe-396 being essential residues 2. MGAT4D transcripts are predominantly expressed in spermatocytes and spermatids, suggesting a role in male spermatogenesis and Sertoli-germ cell interactions 1. Reduced MGAT4D expression has been observed in men with impaired spermatogenesis 1. Additionally, MGAT4D variants show significant gene-based association with blood pressure phenotypes in genome-wide interaction studies with sodium 3, indicating potential involvement in cardiovascular regulation independent of its glycosylation function.